Scroll To Top
News

Treatment Update

Treatment Update

Coverx100_334

The National Institutes of Health's Panel on Clinical Practices for Treatment of HIV Infection has recommended that Viread and Videx EC plus a nonnucleoside reverse transciptase inhibitor not be used as in initial regimen for treatment-naive patients because studies show the regimen has a high failure rate. They panel also recommended that Kaletra be dosed once daily for treatment-naive patients. Once-daily Kaletra dosing is not recommended for treatment-experienced patients.

News
Be sure to follow Plus on your favorite social platform
The Advocates with Sonia BaghdadyOut / Advocate Magazine - Alan Cumming and Jake Shears

From our Sponsors

Most Popular

Lexi Love
News

Lexi Love comes out as HIV+ after Trump deletes federal resources

Ricky Martin performing live at World AIDS Day concert for AIDS Healthcare Foundation
World AIDS Day
Badge
gallery

Ricky Martin delivers showstopping performance for 2024 World AIDS Day

act up protest
Politics

Trump's orders prompt CDC to erase HIV resources

Howard Brown Health mpox vaccine mobile station International Mr Leather conferences Chicago Illinois 2023
Health

California confirms first case of even more deadly mpox strain

This long-term HIV survivor says testosterone therapy helped save his life.
Books

This long-term HIV survivor says testosterone therapy helped save his life.

Latest Stories

HIV Plus Editors

Editor

Read Full Bio